XEBAM Trademark

Trademark Overview

On Tuesday, July 3, 2007, a trademark application was filed for XEBAM with the United States Patent and Trademark Office. The USPTO has given the XEBAM trademark a serial number of 77221617. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 11, 2010. This trademark is owned by Asklepion Pharmaceuticals, LLC. The XEBAM trademark is filed in the Pharmaceutical Products category with the following description:

cholic acid for the treatment of children with inborn defects in bile acid synthesis
xebam

General Information

Serial Number77221617
Word MarkXEBAM
Filing DateTuesday, July 3, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 11, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 18, 2008

Trademark Statements

Goods and Servicescholic acid for the treatment of children with inborn defects in bile acid synthesis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 6, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAsklepion Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBrentwood, TN 37207
Party NameAsklepion Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBrentwood, TN 37207

Trademark Events

Event DateEvent Description
Thursday, December 21, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 2, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 11, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 11, 2010ABANDONMENT - NO USE STATEMENT FILED
Monday, July 6, 2009EXTENSION 2 GRANTED
Wednesday, June 10, 2009EXTENSION 2 FILED
Monday, July 6, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 10, 2009TEAS EXTENSION RECEIVED
Wednesday, December 10, 2008EXTENSION 1 GRANTED
Wednesday, December 10, 2008EXTENSION 1 FILED
Wednesday, December 10, 2008TEAS EXTENSION RECEIVED
Tuesday, June 10, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 18, 2008PUBLISHED FOR OPPOSITION
Wednesday, February 27, 2008NOTICE OF PUBLICATION
Wednesday, February 13, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 13, 2008ASSIGNED TO LIE
Monday, January 14, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 10, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 9, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 9, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 3, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 3, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 15, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 15, 2007NON-FINAL ACTION E-MAILED
Monday, October 15, 2007NON-FINAL ACTION WRITTEN
Wednesday, October 3, 2007ASSIGNED TO EXAMINER
Friday, July 6, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

xebam acid bile synthesis defects children treatment cholic inborn